Items where Author is "Sadeghi, E. S."

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 7.

Article

(2026) Elevated Expression of LINC02257 and LINC00659 in Breast Cancer is Associated with Poor Survival and Immune Cell Infiltration. Current Genetic Medicine Reports. p. 13.

(2025) Arginine-proline metabolism as a prognostic and therapeutic target in triple-negative breast cancer: an in silico and ex vivo investigation. Indian Journal of Clinical Biochemistry. p. 10. ISSN 0970-1915

(2025) Functionalized 3D-printed scaffolds for enhanced osteogenesis and guided bone regeneration. Journal of Materials Chemistry B. pp. 6493-6507. ISSN 2050-750X

(2025) Increased Expression of RCN1P2, TPM3P9, and HSP90AB3P as Non-Coding RNA in Gastric Cancer Linked to Proliferative, Inflammatory and Metastatic Pathways through a Competing Endogenous RNAs Network. Iranian Journal of Public Health. pp. 1074-1086. ISSN 2251-6085

(2025) Therapeutic Potential of PLK1, KIF4A, CDCA5, UBE2C, CDT1, SKA3, AURKB, and PTTG1 Genes in Triple-Negative Breast Cancer: Correlating Their Expression with Sensitivity to GSK 461364 and IKK 16 Drugs. Biochemical genetics. pp. 3845-3862. ISSN 1573-4927 (Electronic) 0006-2928 (Linking)

(2024) Identification of genes related to ribosomal proteins in colorectal cancer: exploring their potential as biomarkers, prognostic indicators, and therapeutic targets. Molecular Biology Reports. p. 16. ISSN 0301-4851

(2024) Therapeutic Potential of PLK1, KIF4A, CDCA5, UBE2C, CDT1, SKA3, AURKB, and PTTG1 Genes in Triple-Negative Breast Cancer: Correlating Their Expression with Sensitivity to GSK 461364 and IKK 16 Drugs. Biochemical Genetics. p. 18. ISSN 0006-2928

This list was generated on Tue Sep 22 22:42:52 2026 +0330.